Press Release The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma ...

Proficio Capital Partners LLC acquired a new position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) in the ...

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...

Injectable drugs market is estimated to be valued at USD 614.07 Billion in 2025 and is expected to reach USD 1,032.78 Billion by 2032, CAGR of 7.7% , 2025-2032 BURLINGAME, CA, UNITED STATES, March ...

This expansion aims to address critical capacity shortages in the US injectable supply chain and meet the growing demand from pharmaceutical companies seeking reliable domestic sterile ...

The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

The FDA has granted orphan drug designation to Plus Therapeutics’ injectable radiotherapy, Rhenium (186Re) Obisbemeda.

Pharma sector is at a tipping point, with potential to become a global leader through agile, efficient, and sustainable ...